Search Results

You searched for : MultipleSclerosis

	ANI Pharmaceuticals announces FDA approval of purified Cortrophin Gel ... Nov 03
	Zydus Cadila receives tentative approval from USFDA for Fingolimod Capsules .25mg It is a sphingosine 1-phosphate receptor modulator indicated for the treatment of relapsing forms of multiple sclerosis (MS).... Jun 24
	European Commission approves Aubagio (teriflunomide) as the first oral MS therapy for first-line treatment of children and adolescents living with relapsing-remitting multiple sclerosis The approval confirms Aubagio as the first oral multiple sclerosis (MS) therapy for first-line treatment of children and adolescents with MS in the European ... Jun 19
	FDA Authorizes Marketing of Device That Can Improve Gait in Multiple Sclerosis Patients FDA is taking an initiative to authorize the marketing of Portable Neuromodulation Stimulator (PoNS) for Multiple Sclerosis patients which can help patients with their motor ... Apr 15
	USFDA approves Rocheâ€™s OCREVUS shorter 2-hour infusion for relapsing and primary progressive multiple sclerosis Shorter infusion time will further improve the twice-yearly treatment experience for OCREVUS, the only B-cell therapy for relapsing and primary progressive MS with ... Dec 15
	Lupin Receives Approval for Dimethyl Fumarate Delayed-Release Capsules After Dr Reddy's, Lupin Ltd. also launches Dimethyl Fumarate Delayed-Release Capsules... Oct 06
	Cipla receives final approval for generic version of Biogen IDEC Inc.â€™s Tecfidera Cipla Limited today announced that it has received final approval for its ANDA for Dimethyl Fumarate Capsules... Sep 25
	Zydus Cadila receives final approval for Dimethyl Fumarate Capsules Dimethyl Fumarate Capsules are indicated for the treatment of multiple sclerosis... Sep 25
8 Matching result(s) found!

-Advertisements-

Trending Now
	Exploring Mortality Risks for Lesbian and Bisexual Women: Key Findings from a Comprehensive Research EffortApril 29, 2024
	Implications of Alcohol Intake During Pregnancy on Fetal Development: New Study Reveals Subtle ChangesApril 29, 2024
	Indian Air Force's Night Vision Rescue: Soldier’s Life Saved in High-Stakes AirliftApril 29, 2024
	Now You Can Also Buy Insurance For Your Parents Aged Above 65 years: IRDAI Lifts Age Cap for Health Insurance Expanding Healthcare AccessApril 29, 2024
	Ensuring Infection Control: Central Government Hospitals Implement New Safety MeasuresApril 29, 2024
	Dish TV Revolutionizes Entertainment with ‘Dish TV Smart+’ Services, Offering TV and OTT on Any Screen, AnywhereApril 26, 2024
	Arohan Financial Services Recognized Among India's Best Workplaces in BFSI 2024April 26, 2024
	Why Podcasts Are the Next Big Thing in Healthcare Advertising in IndiaApril 26, 2024
	Challenges of Child Growth at High Altitudes: New Study Reveals ImpactApril 26, 2024
	Staying Cool in India's Scorching Heat: Heatwave Safety TipsApril 26, 2024
	The Dark Side of Neotame (Artificial Sweetener): New Research Raises Concerns about Gut HealthApril 26, 2024
	Sightsavers India Fellowship Program Invites Applications for Promising OphthalmologistsApril 25, 2024
	Transforming Brain Healthcare: India's Visionary Task Force for Neurological DisordersApril 25, 2024
	The Battle Against Malaria: Rising Trends and Vaccine InnovationsApril 25, 2024
	Talc and Asbestos Controversy: Inside Johnson & Johnson's Courtroom StruggleApril 25, 2024
	The Hidden Struggles of Parenthood: Addressing Isolation, Loneliness, and BurnoutApril 25, 2024
	FDA Confirms Bird Flu Virus Remnants in Pasteurized Milk: Safety and Regulatory InsightsApril 24, 2024
	Sarvodaya Hospital Redefines Total Knee Replacement Surgery with Augmented Reality April 23, 2024
	Fateh Education announces partnership to expand educational opportunities for Indian studentsApril 23, 2024
	10 Strategies to counter disinformation for the healthcare digital ecosystemApril 23, 2024

Search Results

ANI Pharmaceuticals announces FDA approval of purified Cortrophin Gel

Zydus Cadila receives tentative approval from USFDA for Fingolimod Capsules .25mg

European Commission approves Aubagio (teriflunomide) as the first oral MS therapy for first-line treatment of children and adolescents living with relapsing-remitting multiple sclerosis

FDA Authorizes Marketing of Device That Can Improve Gait in Multiple Sclerosis Patients

USFDA approves Rocheâ€™s OCREVUS shorter 2-hour infusion for relapsing and primary progressive multiple sclerosis

Lupin Receives Approval for Dimethyl Fumarate Delayed-Release Capsules

Cipla receives final approval for generic version of Biogen IDEC Inc.â€™s Tecfidera

Zydus Cadila receives final approval for Dimethyl Fumarate Capsules

Trending Now